RS68262B1 - Lečenje alergijskog rinitisa upotrebom kombinacije mometazona i olopatadina - Google Patents
Lečenje alergijskog rinitisa upotrebom kombinacije mometazona i olopatadinaInfo
- Publication number
- RS68262B1 RS68262B1 RS20260779A RSP20260779A RS68262B1 RS 68262 B1 RS68262 B1 RS 68262B1 RS 20260779 A RS20260779 A RS 20260779A RS P20260779 A RSP20260779 A RS P20260779A RS 68262 B1 RS68262 B1 RS 68262B1
- Authority
- RS
- Serbia
- Prior art keywords
- nasal
- treatment
- olopatadine
- allergic rhinitis
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Claims (8)
1. Patentni zahtevi
1. Farmaceutska suspenzija sa fiksnom dozom koja sadrži mometazon-furoat u obliku čestica i olopatadin-hidrohlorid u rastvorenom obliku za upotrebu u lečenju alergijskog rinitisa kod čoveka kojem je to potrebno, pri čemu se (i) suspenzija primenjuje nazalno putem 2 potiska spreja u svaku nozdrvu čoveka dva puta dnevno, i (ii) svaki potisak spreja sadrži 25 µg mometazon-furoata i 665 µg olopatadin-hidrohlorida.
2. Suspenzija za upotrebu prema zahtevu 1, pri čemu se suspenzija primenjuje tokom perioda od najmanje 1 nedelje.
3. Suspenzija za upotrebu prema bilo kom od zahteva 1-2, pri čemu se suspenzija primenjuje tokom perioda od najmanje 2 nedelje.
4. Suspenzija za upotrebu prema bilo kom od zahteva 1-3, pri čemu alergijski rinitis predstavlja sezonski alergijski rinitis ili perenijalni alergijski rinitis i/ili nazalne simptome povezane sa njima.
5. Suspenzija za upotrebu prema zahtevu 4, pri čemu su nazalni simptomi, povezani sa sezonskim alergijskim rinitisom ili perenijalnim alergijskim rinitisom, izabrani između kijanja, svraba u nosu, rinoreje i nazalne kongestije.
6. Suspenzija za upotrebu prema zahtevu 5, pri čemu je nazalni simptom, povezan sa sezonskim alergijskim rinitisom ili perenijalnim alergijskim rinitisom, izabran između kijanja i nazalne kongestije.
7. Suspenzija za upotrebu prema bilo kom od zahteva 1-6, pri čemu čovek pokazuje pozitivan rezultat ubodnog kožnog testa na alergen.
8. Suspenzija za upotrebu prema bilo kom od zahteva 1-7, pri čemu je čovek star najmanje 12 godina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3174MU2013 | 2013-10-04 | ||
| PCT/IB2014/065035 WO2015049665A1 (en) | 2013-10-04 | 2014-10-03 | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| EP14802944.0A EP2922553B1 (en) | 2013-10-04 | 2014-10-03 | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS68262B1 true RS68262B1 (sr) | 2026-07-31 |
Family
ID=51982657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20260779A RS68262B1 (sr) | 2013-10-04 | 2014-10-03 | Lečenje alergijskog rinitisa upotrebom kombinacije mometazona i olopatadina |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10646500B2 (sr) |
| EP (2) | EP2922553B1 (sr) |
| JP (3) | JP6419195B2 (sr) |
| CN (2) | CN112773808A (sr) |
| ES (1) | ES3071407T3 (sr) |
| FI (1) | FI2922553T3 (sr) |
| HK (1) | HK1215674A1 (sr) |
| HR (1) | HRP20260742T1 (sr) |
| LT (1) | LT2922553T (sr) |
| MX (2) | MX2015009429A (sr) |
| MY (1) | MY176808A (sr) |
| PH (1) | PH12015502302A1 (sr) |
| PL (1) | PL2922553T3 (sr) |
| PT (1) | PT2922553T (sr) |
| RS (1) | RS68262B1 (sr) |
| RU (1) | RU2686670C2 (sr) |
| SI (1) | SI2922553T1 (sr) |
| SM (1) | SMT202600244T1 (sr) |
| UA (1) | UA120587C2 (sr) |
| WO (1) | WO2015049665A1 (sr) |
| ZA (1) | ZA201504740B (sr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| MX2015009429A (es) * | 2013-10-04 | 2015-10-09 | Glenmark Pharmaceuticals Ltd | Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina. |
| US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| CN115444851A (zh) * | 2017-06-28 | 2022-12-09 | 格兰马克专业公司 | 用于治疗鼻炎的分配装置和药物组合物 |
| CN111787954B (zh) * | 2018-02-23 | 2023-09-05 | 格兰马克专业公司 | 使用莫美他松和奥洛他定的组合治疗儿科受试者的过敏性鼻炎 |
| US12303635B2 (en) | 2018-04-16 | 2025-05-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| PE44995A1 (es) | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| EP1227812B1 (en) | 1999-10-08 | 2007-04-18 | Schering Corporation | Topical nasal treatment using desloratadine and mometasone furoate |
| US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| CA2504200A1 (en) * | 2002-11-12 | 2004-05-27 | Alcon, Inc. | The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| PL1814538T3 (pl) | 2004-11-24 | 2010-02-26 | Alcon Inc | Sposób dostarczania donosowego sprayu |
| PT1919450E (pt) * | 2005-09-01 | 2014-09-10 | Meda Ab | Composição lipossomal contendo anti-histamínico e corticosteróide e sua utilização para a preparação de um medicamento para o tratamento de rinite e distúrbios relacionados |
| EP1968548A2 (en) | 2005-12-02 | 2008-09-17 | Elan Pharma International Limited | Mometasone compositions and methods of making and using the same |
| RU2434652C2 (ru) | 2006-04-21 | 2011-11-27 | Токо Якухин Когио Кабусики Кайся | Емкость для текучей среды и система безвоздушного дозирования текучей среды с использованием упомянутой емкости |
| JP2010531898A (ja) * | 2007-06-28 | 2010-09-30 | サイデックス・ファーマシューティカルズ・インコーポレイテッド | 鼻および眼へのコルチコステロイド水溶液送達 |
| EP2318049A1 (en) * | 2008-07-15 | 2011-05-11 | Schering Corporation | Intranasal compositions comprising a decongestant and a corticosteroid |
| US8642069B2 (en) | 2008-08-27 | 2014-02-04 | Alexander D. Goldin | Composition and method for treating colds |
| BR112012001169A2 (pt) | 2009-07-17 | 2016-03-01 | Alcon Res Ltd | sistema de pulverização nasal de olopatadina para crianças |
| CN102078326A (zh) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | 含有聚维酮碘与糠酸莫米松的局部使用组合物 |
| CN102078285A (zh) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶 |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| JP5683719B2 (ja) | 2011-01-04 | 2015-03-11 | イスタ・ファーマシューティカルズ・インコーポレイテッドＩｓｔａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | ベポタスチン組成物 |
| CN104755615A (zh) | 2012-10-25 | 2015-07-01 | 诺维信公司 | 用于餐具洗涤的改进的方法 |
| KR20140081925A (ko) | 2012-12-12 | 2014-07-02 | 한미약품 주식회사 | 코르티코스테로이드, 항히스타민제 및 스테비아를 포함하는 고미 차폐된 약학 제제 |
| UA116793C2 (uk) | 2013-09-13 | 2018-05-10 | Гленмарк Спешіалті С.А. | Стабільна фармацевтична композиція з фіксованою дозою, що містить мометазон й олопатадин |
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| MX2015009429A (es) * | 2013-10-04 | 2015-10-09 | Glenmark Pharmaceuticals Ltd | Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina. |
-
2014
- 2014-10-03 MX MX2015009429A patent/MX2015009429A/es active IP Right Grant
- 2014-10-03 RU RU2015128496A patent/RU2686670C2/ru active
- 2014-10-03 PT PT148029440T patent/PT2922553T/pt unknown
- 2014-10-03 SM SM20260244T patent/SMT202600244T1/it unknown
- 2014-10-03 RS RS20260779A patent/RS68262B1/sr unknown
- 2014-10-03 HK HK16103630.2A patent/HK1215674A1/zh unknown
- 2014-10-03 EP EP14802944.0A patent/EP2922553B1/en active Active
- 2014-10-03 JP JP2016546191A patent/JP6419195B2/ja active Active
- 2014-10-03 MY MYPI2015702416A patent/MY176808A/en unknown
- 2014-10-03 PL PL14802944.0T patent/PL2922553T3/pl unknown
- 2014-10-03 HR HRP20260742TT patent/HRP20260742T1/hr unknown
- 2014-10-03 LT LTEPPCT/IB2014/065035T patent/LT2922553T/lt unknown
- 2014-10-03 ES ES14802944T patent/ES3071407T3/es active Active
- 2014-10-03 FI FIEP14802944.0T patent/FI2922553T3/fi active
- 2014-10-03 WO PCT/IB2014/065035 patent/WO2015049665A1/en not_active Ceased
- 2014-10-03 EP EP23198254.7A patent/EP4272839A3/en active Pending
- 2014-10-03 US US14/506,122 patent/US10646500B2/en active Active
- 2014-10-03 CN CN202110299649.8A patent/CN112773808A/zh active Pending
- 2014-10-03 SI SI201432127T patent/SI2922553T1/sl unknown
- 2014-10-03 CN CN201480066538.0A patent/CN105792828A/zh active Pending
- 2014-10-03 UA UAA201507124A patent/UA120587C2/uk unknown
-
2015
- 2015-07-01 ZA ZA2015/04740A patent/ZA201504740B/en unknown
- 2015-07-22 MX MX2020003035A patent/MX2020003035A/es unknown
- 2015-10-05 PH PH12015502302A patent/PH12015502302A1/en unknown
-
2018
- 2018-04-11 JP JP2018076047A patent/JP6768733B2/ja active Active
-
2020
- 2020-02-21 JP JP2020028523A patent/JP2020097624A/ja active Pending